Assertio Holdings, Inc. - 8-K Filing
Assertio Holdings agreed with Garda Therapeutics to delay the launch of a tender offer for all outstanding shares until May 14, 2026; under an amended merger agreement, Garda will acquire Assertio at $21.80 per share in cash totaling $153.2 million. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $ASRT